
Can-Fite BioPharma Ltd. CANF
$ 0.29
-5.01%
Annual report 2024
added 11-29-2025
Can-Fite BioPharma Ltd. DSO Ratio 2011-2025 | CANF
Annual DSO Ratio Can-Fite BioPharma Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 28.1 | 46.9 | 1.37 K | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.37 K | 28.1 | 482 |
DSO Ratio of other stocks in the Biotechnology industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AbbVie
ABBV
|
267 | $ 223.01 | -0.99 % | $ 395 B | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
31.5 | $ 4.68 | 1.85 % | $ 777 M | ||
|
Aclaris Therapeutics
ACRS
|
6.01 | $ 3.38 | 3.21 % | $ 261 M | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
25 | - | -15.15 % | $ 60.3 M | ||
|
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | ||
|
Ascendis Pharma A/S
ASND
|
132 | $ 212.3 | 5.5 % | $ 5 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
14.7 | - | -0.23 % | $ 916 M | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
Aptorum Group Limited
APM
|
20.6 | $ 1.33 | -1.48 % | $ 7.25 M | ||
|
Alterity Therapeutics Limited
ATHE
|
16.2 K | $ 3.4 | 1.49 % | $ 8.18 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
62.6 | $ 25.76 | 0.19 % | $ 1.25 B | ||
|
Anika Therapeutics
ANIK
|
77.3 | $ 9.53 | -1.19 % | $ 140 M | ||
|
Brickell Biotech
BBI
|
254 | - | -5.38 % | $ 6.06 M | ||
|
BeiGene, Ltd.
BGNE
|
49.5 | - | 0.49 % | $ 251 B | ||
|
Biogen
BIIB
|
57.9 | $ 173.03 | -2.55 % | $ 25.2 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
6.09 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
103 | - | -7.31 % | $ 87 M | ||
|
Aytu BioScience
AYTU
|
150 | $ 2.33 | 2.3 % | $ 14.6 M | ||
|
Arena Pharmaceuticals
ARNA
|
946 | - | -6.81 % | $ 3.04 B | ||
|
Baudax Bio
BXRX
|
126 | - | 0.59 % | $ 63 K | ||
|
Catalyst Biosciences
CBIO
|
3.24 | $ 15.32 | 5.73 % | $ 1.01 B | ||
|
ChromaDex Corporation
CDXC
|
13.2 | - | -0.88 % | $ 598 M | ||
|
Axon Enterprise
AXON
|
134 | $ 586.28 | 3.15 % | $ 44.4 B | ||
|
Cerus Corporation
CERS
|
59.2 | $ 2.14 | 13.23 % | $ 395 M | ||
|
Checkpoint Therapeutics
CKPT
|
6.83 | - | - | $ 169 M | ||
|
Caladrius Biosciences
CLBS
|
164 | - | -16.75 % | $ 25.8 M | ||
|
Celldex Therapeutics
CLDX
|
86.5 | $ 28.33 | 0.5 % | $ 1.82 M | ||
|
Clovis Oncology
CLVS
|
65.5 | - | -7.23 % | $ 13 M | ||
|
Benitec Biopharma
BNTC
|
141 | $ 12.91 | 0.78 % | $ 531 M | ||
|
Cytokinetics, Incorporated
CYTK
|
177 | $ 60.38 | 0.11 % | $ 6.76 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
60.8 | - | - | $ 2.18 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
169 | $ 11.55 | 8.86 % | $ 747 M | ||
|
Dynavax Technologies Corporation
DVAX
|
56.5 | $ 10.89 | -0.09 % | $ 1.42 B | ||
|
Eloxx Pharmaceuticals
ELOX
|
157 | - | -5.68 % | $ 8.28 M |